Check Black Diamond Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$179.9M
EPS (TTM)
0.34
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
13.17
Industry PE ratio
-3.9415151515151514
P/B Ratio
13.1667
PEG Ratio
0EBITDA
8.0M
Revenue (TTM)
70.0M
Profit Margin
20.63%
Return On Equity TTM
11.85%
Track how Black Diamond Therapeutics P/E has moved over time to understand its valuation trends.
Black Diamond Therapeutics in the last 5 years
Lowest (8.21x)
June 30, 2025
Industry (-3.94x)
September 18, 2025
Today (13.17x)
September 18, 2025
Highest (32.41x)
March 31, 2025
Today’s Price to Earnings Ratio: 13.17x
Compare market cap, revenue, PE, and other key metrics of Black Diamond Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $179.9M | -89.5% | 13.17 | 20.63% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Black Diamond Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Black Diamond Therapeutics investment value today
Current value as on today
₹74,509
Returns
Returns from Black Diamond Therapeutics Stock
Dollar Returns*
₹4,953 (+4.95%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Black Diamond Therapeutics. Average target price of $9.8
Get share price movements and forecasts by analysts on Black Diamond Therapeutics.
What analysts predicted
66.43%UPSIDE
Target Price
$9.8
Current Price
$3.29
Analyzed by
12 Analysts
Target
$9.80
Black Diamond Therapeutics target price $9.8, a slight upside of 66.43% compared to current price of $3.29. According to 12 analysts rating.
Search interest for Black Diamond Therapeutics Stock has increased by 54% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:54% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 6 months, BDTX stock has moved up by 88.1%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 88.1%
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 101.6%
Organisation | Black Diamond Therapeutics |
Headquarters | One Main Street, Cambridge, MA, United States, 02142 |
Industry | Health Technology |
CEO | Dr. Mark A. Velleca M.D., Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Elizabeth Buck Ph.D. | Co-Founder & Chief Scientific Officer |
Ms. Erika Jones | Principal Financial Officer, Principal Accounting Officer, SVP of Finance & Corporate Controller |
Ms. Melanie Morrison | Chief Development Officer |
Dr. Mark A. Velleca M.D., Ph.D. | CEO, President & Chairman |
Mr. Brent Hatzis-Schoch Esq., J.D. | COO & General Counsel |
Dr. Sergey Yurasov M.D., Ph.D. | Chief Medical Officer |
Black Diamond Therapeutics share price today is $3.29 as on . Black Diamond Therapeutics share today touched a day high of $3.29 and a low of $3.21.
Black Diamond Therapeutics share touched a 52 week high of $5.69 on and a 52 week low of $1.2 on . Black Diamond Therapeutics stock price today i.e. is trending at $3.29,which is 42.18% down from its 52 week high and 175.31% up from its 52 week low.
Black Diamond Therapeutics market capitalisation is $0.00T as on .
Indian investors can start investing in Black Diamond Therapeutics (BDTX) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Black Diamond Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Black Diamond Therapeutics share’s latest price of $3.29 as on September 18, 2025 at 10:38 pm IST, you will get 3.0395 shares of Black Diamond Therapeutics. Learn more about
fractional shares .
Black Diamond Therapeutics stock has given -89.5% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?